Leaderboard
Insiders and issuers ranked by realized signed return on open-market Form 4 trades. Returns are signed: a sale followed by a rally counts against the seller.
What the metrics mean
Return - the insider's signed return per trade, averaged. A +10% stock move on a buy scores +10%; on a sell, -10%. Because most insider activity is concentrated at rallying stocks, this metric correlates with raw stock performance and doesn't fully isolate timing skill from market drift.
Edge - signed return minus the stock's average forward N-day return over the same period. An insider with +5% edge consistently chose better days to trade than someone who'd picked a random day in the same window. Isolates timing skill from "the stock just went up."
Neither metric is the same as ranking stocks by raw return - that would just surface the best-performing tickers, which you can get from any market screener.
Issuers ranked
1,534
Showing 50 of 1,534
Quality filters
10+ trades
≥3 insiders, 50% price coverage
Window
5y trailing
Trade date filter
| # | Ticker | Issuer | Trades | Insiders | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|---|---|
| 1 | NEGG | Newegg Commerce, Inc. | 46 | 3 | 70% | +161.7% | +227.3% | +336.7% | -56.9% |
| 2 | SKYE | Skye Bioscience, Inc. | 18 | 9 | 89% | +149.9% | +22.4% | +318.3% | -13.6% |
| 3 | YELLQ | Yellow Corp | 38 | 16 | 63% | +89.2% | +18.8% | +256.2% | -34.5% |
| 4 | TKNO | Alpha Teknova, Inc. | 35 | 13 | 80% | +79.9% | +21.2% | +217.2% | -22.5% |
| 5 | PAPL | Pineapple Financial Inc. | 90 | 4 | 89% | +77.0% | +57.9% | +325.0% | -21.9% |
| 6 | TOI | Oncology Institute, Inc. | 29/32 | 10 | 97% | +70.2% | +16.4% | +173.6% | -1.4% |
| 7 | PHAT | Phathom Pharmaceuticals, Inc. | 23 | 6 | 70% | +70.1% | +9.7% | +271.7% | -20.0% |
| 8 | EVLO | Evelo Biosciences, Inc. | 72 | 14 | 100% | +67.4% | +4.7% | +192.9% | +4.7% |
| 9 | HYMC | Hycroft Mining Holding Corp | 63 | 3 | 83% | +64.9% | +47.7% | +167.0% | -24.5% |
| 10 | CAUD | Collective Audience, Inc. | 19/23 | 7 | 26% | +59.1% | -27.7% | +493.8% | -43.9% |
| 11 | LFMD | Lifemd, Inc. | 21 | 8 | 90% | +57.5% | +61.5% | +121.1% | -17.0% |
| 12 | OCX | Oncocyte Corp | 75/141 | 15 | 76% | +55.6% | +66.9% | +107.5% | -4.7% |
| 13 | HLLY | Holley Inc. | 19 | 9 | 95% | +55.0% | +76.3% | +76.3% | -1.4% |
| 14 | FOSL | Fossil Group, Inc. | 12/13 | 7 | 100% | +54.5% | +58.3% | +86.3% | +1.9% |
| 15 | UPXI | Upexi, Inc. | 18/36 | 4 | 72% | +54.0% | +3.1% | +320.0% | -27.9% |
| 16 | SANA | Sana Biotechnology, Inc. | 46 | 16 | 100% | +53.4% | +54.2% | +54.2% | +18.4% |
| 17 | STLY | Hg Holdings, Inc. | 15 | 3 | 100% | +51.2% | +51.2% | +51.2% | +51.2% |
| 18 | STTK | Shattuck Labs, Inc. | 20 | 9 | 70% | +49.7% | +12.0% | +136.4% | -33.2% |
| 19 | RLMD | Relmada Therapeutics, Inc. | 35 | 6 | 91% | +49.5% | +53.6% | +170.1% | -18.2% |
| 20 | SENS | Senseonics Holdings, Inc. | 11/12 | 4 | 100% | +47.4% | +19.1% | +152.3% | +11.1% |
| 21 | ELYM | Eliem Therapeutics, Inc. | 28/35 | 7 | 100% | +46.7% | +34.8% | +104.3% | +12.9% |
| 22 | DKDCA | Data Knights Acquisition Corp. | 77/78 | 4 | 66% | +46.3% | +20.2% | +297.2% | -55.2% |
| 23 | USGO | U.S. Goldmining Inc. | 35 | 5 | 83% | +46.0% | +59.0% | +77.0% | -19.9% |
| 24 | TRDA | Entrada Therapeutics, Inc. | 174/175 | 7 | 96% | +45.6% | +45.9% | +94.7% | -12.9% |
| 25 | TENX | Tenax Therapeutics, Inc. | 17 | 6 | 88% | +44.3% | +60.4% | +79.0% | -11.4% |
| 26 | FTCI | Ftc Solar, Inc. | 46/50 | 11 | 78% | +44.2% | +39.9% | +136.6% | -30.4% |
| 27 | HEPA | Hepion Pharmaceuticals, Inc. | 13 | 6 | 54% | +42.9% | +12.1% | +127.5% | -22.0% |
| 28 | ZIVO | Zivo Bioscience, Inc. | 42 | 7 | 45% | +42.3% | -1.2% | +728.3% | -45.2% |
| 29 | LOCL | Local Bounti Corporation/De | 35 | 8 | 80% | +41.7% | +53.6% | +111.4% | -28.8% |
| 30 | MLCT | Malachite Innovations, Inc. | 17/34 | 4 | 65% | +41.6% | +17.6% | +123.5% | -21.1% |
| 31 | WVE | Wave Life Sciences Ltd. | 35 | 5 | 97% | +40.9% | +11.9% | +141.5% | -17.0% |
| 32 | SNWV | Sanuwave Health, Inc. | 13 | 6 | 92% | +40.6% | +45.1% | +68.9% | -34.3% |
| 33 | LGMK | Logicmark, Inc. | 13 | 3 | 100% | +40.0% | +20.6% | +73.1% | +10.5% |
| 34 | BFLY | Butterfly Network, Inc. | 17 | 4 | 88% | +39.9% | +43.4% | +78.3% | -34.4% |
| 35 | INSG | Inseego Corp. | 11 | 5 | 82% | +39.8% | +48.3% | +59.5% | -12.0% |
| 36 | COCH | Envoy Medical, Inc. | 16 | 6 | 56% | +38.3% | +39.4% | +132.0% | -23.3% |
| 37 | GENK | Gen Restaurant Group, Inc. | 88 | 7 | 92% | +37.4% | +42.8% | +60.3% | -19.6% |
| 38 | UEC | Uranium Energy Corp | 13 | 3 | 69% | +37.2% | +57.0% | +57.0% | -7.3% |
| 39 | IOVA | Iovance Biotherapeutics, Inc. | 16 | 8 | 81% | +36.1% | +47.3% | +79.8% | -43.7% |
| 40 | NRGV | Energy Vault Holdings, Inc. | 28 | 8 | 82% | +36.1% | +43.3% | +88.8% | -17.7% |
| 41 | ASPI | Asp Isotopes Inc. | 26 | 7 | 69% | +35.5% | +52.8% | +100.0% | -43.9% |
| 42 | PACK | Ranpak Holdings Corp. | 33 | 7 | 82% | +35.5% | +48.6% | +63.4% | -40.5% |
| 43 | TCRX | Tscan Therapeutics, Inc. | 74 | 12 | 82% | +35.0% | +50.5% | +52.3% | -31.7% |
| 44 | HOWL | Werewolf Therapeutics, Inc. | 19 | 5 | 100% | +34.9% | +23.2% | +74.7% | +23.0% |
| 45 | BLTH | American Battery Materials, Inc. | 33 | 10 | 61% | +34.1% | +33.3% | +125.0% | -22.2% |
| 46 | GOSS | Gossamer Bio, Inc. | 12 | 5 | 67% | +33.8% | +27.9% | +109.6% | -16.5% |
| 47 | ALMS | Alumis Inc. | 154 | 15 | 62% | +33.8% | +43.7% | +114.2% | -53.4% |
| 48 | SHFS | Shf Holdings, Inc. | 35 | 10 | 86% | +33.7% | +39.2% | +81.3% | -13.4% |
| 49 | MANE | Veradermics, Inc | 90 | 11 | 100% | +32.6% | +28.6% | +38.1% | +28.6% |
| 50 | SNBR | Sleep Number Corp | 91 | 13 | 97% | +32.0% | +30.9% | +56.0% | -52.4% |
Showing 1-50 of 1,534